Xlife Sciences AG
Develops and commercializes early-stage life sciences research projects.
XLS | SW
Overview
Corporate Details
- ISIN(s):
- CH0461929603 (+1 more)
- LEI:
- 984500AH590BE88BB517
- Country:
- Switzerland
- Address:
- Talacker 35, 8001 Zürich
Description
Xlife Sciences AG is a life sciences company that specializes in the value development and commercialization of early-stage research projects. The company identifies promising technologies from universities and other research institutions, acting as an incubator and accelerator to bridge the gap between academic research and healthcare markets. Its operations are focused on four core areas: technology platforms, biotechnologies and therapies, medical technology (health technology), and the application of artificial intelligence in life sciences and digital health. The primary objective is to develop solutions that address high unmet medical needs and improve quality of life.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-28 13:10 |
Xlife Sciences AG Provides Update on VERAXA Biotech AGs NASDAQ Listing Process …
|
English | HTML • 9.0 KB | ||
| 2025-11-28 01:00 |
Xlife Sciences AG Provides Update on VERAXA Biotech AG’s NASDAQ Listing Process…
|
English | HTML • 11.7 KB | ||
| 2025-11-28 01:00 |
Xlife Sciences AG gibt ein Update zum Stand des NASDAQ-Listing-Prozesses der VE…
|
German | HTML • 12.0 KB | ||
| 2025-10-16 07:00 |
Xlife Sciences AG Publishes 2024 ESG Report: Sustainable Value Creation as a St…
|
English | HTML • 8.0 KB | ||
| 2025-10-16 02:00 |
Xlife Sciences AG Publishes 2024 ESG Report: Sustainable Value Creation as a St…
|
English | HTML • 10.2 KB | ||
| 2025-10-16 02:00 |
Xlife Sciences AG veröffentlicht ESG-Bericht 2024: Nachhaltige Wertschöpfung al…
|
German | HTML • 9.8 KB | ||
| 2025-09-23 07:00 |
Xlife Sciences AG Half-Year Report 2025: Focus on VERAXA Biotech AGs NASDAQ Lis…
|
English | HTML • 7.0 KB | ||
| 2025-09-23 02:00 |
Xlife Sciences AG Half-Year Report 2025: Focus on VERAXA Biotech AG’s NASDAQ Li…
|
English | HTML • 9.5 KB | ||
| 2025-09-23 02:00 |
Xlife Sciences AG Halbjahresbericht 2025: Fokus auf NASDAQ-Listing der VERAXA B…
|
German | HTML • 13.3 KB | ||
| 2025-07-17 07:00 |
Xlife Sciences AGs Portfolio Company, VERAXA Biotech AG, Takes Key Step Toward …
|
English | HTML • 12.6 KB | ||
| 2025-07-17 02:00 |
Xlife Sciences AG’s Portfolio Company, VERAXA Biotech AG, Takes Key Step Toward…
|
English | HTML • 15.5 KB | ||
| 2025-07-17 02:00 |
Portfoliounternehmen der Xlife Sciences AG, VERAXA Biotech AG, erreicht wichtig…
|
German | HTML • 16.4 KB | ||
| 2025-06-24 18:00 |
Xlife Sciences AG: Successful General Meeting and Growth Prospects for 2025
|
English | HTML • 6.1 KB | ||
| 2025-06-24 02:00 |
Xlife Sciences AG: Successful General Meeting and Growth Prospects for 2025
|
English | HTML • 8.2 KB | ||
| 2025-06-24 02:00 |
Xlife Sciences AG: Erfolgreiche Generalversammlung und Wachstumsaussichten in 2…
|
German | HTML • 8.5 KB |
Automate Your Workflow. Get a real-time feed of all Xlife Sciences AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Xlife Sciences AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Xlife Sciences AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-06-15 | N/A | Executive member | Buy | None | 6,000.00 CHF |
| 2022-06-15 | N/A | Executive member | Buy | None | 3,000.00 CHF |
| 2022-06-14 | N/A | Executive member | Buy | None | 15,500.00 CHF |
| 2022-06-10 | N/A | Executive member | Buy | None | 6,728.90 CHF |
| 2022-06-07 | N/A | Executive member | Buy | None | 34,800.00 CHF |
| 2022-06-03 | N/A | Executive member | Buy | None | 3,540.00 CHF |
| 2022-05-24 | N/A | Executive member | Buy | None | 3,400.00 CHF |
| 2022-05-17 | N/A | Executive member | Buy | None | 10,794.20 CHF |
| 2022-05-13 | N/A | Executive member | Buy | None | 3,690.00 CHF |
| 2022-05-10 | N/A | Executive member | Buy | None | 1,935.00 CHF |
Peer Companies
